GLIDE PHARMA

USPTO USPTO 2008 CANCELLED - SECTION 8

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The US trademark GLIDE PHARMA was filed as Word mark on 02/20/2008 at the U.S. Patent and Trademark Office.
It was registered as a trademark on 04/27/2010. The current status of the mark is "CANCELLED - SECTION 8".

Trademark Details Last update: August 14, 2019

Trademark form Word mark
File reference 77401647
Register number 3779916
Application date February 20, 2008
Publication date February 9, 2010
Entry date April 27, 2010

Trademark owner

45b Milton Park
OX144RU Abingdon, Oxfordshire
GB

Trademark representatives

goods and services

5 Pharmaceutical and veterinary preparations and substances for the diagnosis of, treatment of or protection against infectious diseases, pain, inflammation and obesity; pharmaceutical and veterinary preparations and substances for the diagnosis of, treatment of or protection against viral, metabolic, musculoskeletal, central nervous system, endocrinological, immunological, oncological, neurological, hormonal, dermatological and psychiatric related diseases and disorders; pharmaceutical and veterinary preparations and substances for skin and tissue repair; prophylactic pharmaceutical and veterinary preparations and substances; vaccines, prophylactic vaccines, therapeutic vaccines; contraceptive preparations and substances; all the aforesaid being in solid dosage form
10 Needleless medical device for delivering pharmaceuticals in solid doses under the skin; needleless drug delivery devices; biological sampling apparatus including fluid and tissue collectors and samplers, and parts and fittings therefor; actuator devices for use in drug delivery devices; drug cassettes for use in drug delivery devices to contain pharmaceutical preparations and substances for therapeutic, prophylactic and diagnostic use all being in the form of solid doses; parts and fittings for all the aforesaid goods
42 Services in the design, development and formulation of pharmaceuticals into a solid dosage format; research and development services in relation to the delivery of pharmaceuticals in a solid dosage format

ID: 1377401647